Andrew M. Beato Partner
Andrew M. Beato is the Chair of the False Claims Act and Whistleblower Practice Group at Stein Mitchell Beato & Missner LLP. His practice focuses on representing whistleblowers in the United States and abroad. Mr. Beato has substantial experience representing clients in high-profile government fraud investigations with state and federal agencies, including the Department of Justice, State Attorneys General Offices, the Food and Drug Administration, the U.S. Department of Health and Human Services, the Centers for Medicare and Medicaid Services, the Securities and Exchange Commission, the Internal Revenue Service, and the Department of Defense. In addition, Mr. Beato represents clients in complex international whistleblower claims involving financial entities alleged to have violated tax, securities, commodities, and health care laws. The whistleblowers represented by Mr. Beato have contributed to more than $3.5 billion in payments to federal and state governments, including $2.6 billion paid by Credit Suisse for conspiring to aid and assist taxpayers in filing false returns.
Honors & Awards
WASHINGTON’S TOP LAWYERS (2013-2017)
- WASHINGTONIAN Magazine selects Andrew Beato for his outstanding record of achievement as a Whistleblower lawyer.
THE NATIONAL TRIAL LAWYERS TOP 100 TRIAL LAWYERS (2014-2018)
Community & Professional Activities
Member, American Bar Association
Member, Maryland State Bar Association
Member, District of Columbia Bar Association
USD 2.5 million vs. USD 42,325: Huge gap in J&J hip-implant compensations in the US and India proves the need for urgent reforms.March 5, 2019
January 29, 2019
Watch CBS Program Featuring Andrew Beato’s Client Dr. Michael JonesJanuary 2019
A Landmark Settlement with Lessons Learned for Compliance OfficersJanuary 25, 2019
Walgreens To Pay Feds And States $60M In Largest-Ever Settlement By A Pharmacy Chain For Overcharging For DrugsJanuary 22, 2019
October 31, 2018
Stein Mitchell Represented a Successful Whistleblower in $50 million Settlement of a Civil Fraud LawsuitJanuary 19, 2017
Worth the price? Push for cheaper generic drugs has Canadians buying questionable medicines from IndiaWhistleblower represented by Andrew Beato uncovers questionable manufacturing standards, manipulated records and defective drugs at Ranbaxy LaboratoriesOriginally Published in The National Post
Co-author, The Law of Law Firms (West) (2d ed. 2012).
Chapter Co-author, ABA Consumer Law Developments
Author, Newly Independent and Separating States' Succession to Treaties, 9 Am. U.J. Int'l & Pol'y 525 (1994).
- District of Columbia
- Fourth Circuit Court of Appeals
American University, The Washington College of Law, J.D.
- Staff editor, The American University Journal of International Law and Policy
Boston University, 1991, summa cum laude with distinction, Phi Beta Kappa